Myocardial Cell Preservation from Potential Cardiotoxic Drugs: The Role of Nanotechnologies.

Iervolino, Adelaide; Spadafora, Luigi; Spadaccio, Cristiano; Iervolino, Valentina; Biondi Zoccai, Giuseppe; Andreotti, Felicita

Iervolino, Adelaide; Spadafora, Luigi; Spadaccio, Cristiano; Iervolino, Valentina; Biondi Zoccai, Giuseppe; Andreotti, Felicita.

Afiliación

Iervolino A; Department of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy.
Spadafora L; Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, 00189 Rome, Italy.
Spadaccio C; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Iervolino V; Centre Hospitalier Universitaire Henri-Mondor, Faculté de Médecine, Université Paris Est Créteil, 94000 Créteil, France.
Biondi Zoccai G; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 00189 Rome, Italy.
Andreotti F; Mediterranea Cardiocentro, 80122 Napoli, Italy.

Pharmaceutics ; 15(1)2022 Dec 27.

Article en En | MEDLINE | ID: mdl-36678717

Palabras clave

cardio-oncology; cardiomyocytes; cardiotoxicity; delivery systems; dendrimers; liposomes; nanoparticles

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2022 Tipo del documento: Article País de afiliación: Italia